PALO ALTO, CA, Oct. 17, 2013 /PRNewswire/ - The PAWS Pet
Company, Inc. (OTCQB:PAWS), is pleased to announce that the three
short-term convertible notes that were negotiated with Asher
Enterprises, Inc. in 2012 have been paid in full. The final
interest payment on the last of those notes was paid today.
The Company is also taking steps to settle most of the remaining
debt on its books as part of its ongoing process of moving from the
pet space to the pharmaceutical space. Management has received
positive responses from several of these important stakeholders and
hopes to finalize this process soon.
In further news, the Company believes that an agreement with
Pharmacy Development Inc. dba MESA Pharmacy ("MESA") is in its
final stages. The Company will update shareholders as events
warrant.
About The PAWS Pet Company, Inc.
The PAWS Pet Company, Inc. is undergoing a transition from the
pet space to the pharmaceutical space. This exciting transition
strategy has been developed to take advantage of the changes
underway in traditional medical services. PAWS believes that great
opportunities exist in pharmaceuticals and how they are delivered
to the public.
For more information on The PAWS Pet Company go to
www.thepawspetcompany.com
Company Contact: ir@thepawspetcompany.com
Forward-Looking Statements
Certain statements made in this press release are
forward-looking in nature (within the meaning of the Private
Securities Litigation Reform Act of 1995) and, accordingly, are
subject to risks and uncertainties. The actual results may differ
materially from those described or contemplated and consequently,
you should not rely on these forward-looking statements as
predictions of future events. Certain of these risks and
uncertainties are discussed in the reports we filed with the
SEC.
Contact: ir@thepawspetcompany.com
SOURCE The PAWS Pet Company, Inc.